2,788
Views
41
CrossRef citations to date
0
Altmetric
Pilot Study on UMTS Exposure on ENU-Induced Tumors

Indication of cocarcinogenic potential of chronic UMTS-modulated radiofrequency exposure in an ethylnitrosourea mouse model

, , , , , & show all
Pages 529-541 | Received 29 May 2009, Accepted 09 Feb 2010, Published online: 15 Jun 2010
 

Abstract

Purpose: To evaluate putative effects on tumour susceptibility in mice exposed to a UMTS (universal mobile telecommunications system) test signal for up to 24 months, commencing with embryo-fetal exposure.

Material and methods: Animals were exposed to UMTS fields with intensities of 0, 4.8, and 48 W/m2, the low-dose group (4.8 W/m2) was subjected to additional prenatal ethylnitrosourea treatment (40 mg ENU/kg body weight).

Results: The high-level UMTS exposure (48 W/m2), the sham exposure, and the cage control groups showed comparable tumour incidences in the protocol organs. In contrast, the ENU-treated group UMTS-exposed at 4.8 W/m2 displayed an enhanced lung tumour rate and an increased incidence of lung carcinomas as compared to the controls treated with ENU only. Furthermore, tumour multiplicity of the lung carcinomas was increased and the number of metastasising lung tumours was doubled in the ENU/UMTS group as compared to the ENU control group.

Conclusion: This pilot study indicates a cocarcinogenic effect of lifelong UMTS exposure (4.8 W/m2) in female B6C3F1 descendants subjected to pretreatment with ethylnitrosourea.

Acknowledgements

The authors wish to thank Dr. Lorenzo Tomatis (†, Trieste, Italy) and Prof. Ulrich Mohr (Hannover, Germany) for their valuable and constructive project monitoring. The fruitful technical supervision of the project by Prof. Flavio Canavero (Dipartimento di Elettronica, Politecnico Torino, Torino, Italy) is also acknowledged. The project was funded by the Compagnia di San Paolo, Torino, Italy. Grant number: 11581/23718.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.